United States · FDA National Drug Code directory

Rizatriptan

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1352_9f140953-589f-43ab-b977-a5c48c5853c1
Product NDC
71335-1352
Form
TABLET, FILM COATED
Composition / generic term
Rizatriptan
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20140311
Source listing expiry
20261231

Source-listed ingredients

  • RIZATRIPTAN BENZOATE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-1) · 71335-1352-1
  • 6 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-2) · 71335-1352-2
  • 90 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-3) · 71335-1352-3
  • 9 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-4) · 71335-1352-4
  • 30 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-5) · 71335-1352-5
  • 18 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-6) · 71335-1352-6
  • 12 TABLET, FILM COATED in 1 BLISTER PACK (71335-1352-7) · 71335-1352-7

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Rizatriptan — United States | Molindra Medicines